Capricor Therapeutics, Inc. Profile Avatar - Palmy Investing

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an…

Biotechnology
US, San Diego [HQ]

News

Theses · Events · Sentiments
End of CAPR's Analysis
CIK: 1133869 CUSIP: 14070B309 ISIN: US14070B3096 LEI: - UEI: -
Secondary Listings
CAPR has no secondary listings inside our databases.